Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 06, 2019 at 03:05 pm EST
Share
Medeon Biodesign, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 125.443 million compared to TWD 63.293 million a year ago. Operating loss was TWD 69.040 million compared to TWD 64.395 million a year ago. Net loss was TWD 69.906 million compared to TWD 48.460 million a year ago. Basic loss per share was TWD 1.05 compared to TWD 0.85 a year ago. For the nine months, sales was TWD 331.870 million compared to TWD 593.144 million a year ago. Operating loss was TWD 196.325 million compared to operating Income of TWD 227.793 million a year ago. Net loss was TWD 178.614 million compared to net income of TWD 299.131 million a year ago. Basic loss per share was TWD 2.71 compared to basic earnings per share of TWD 5.24 a year ago. Diluted loss per share was TWD 2.71 compared to diluted earnings per share of TWD 5.18 a year ago.
Medeon Biodesign, Inc. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of medical equipment. The Company's main products include medical apparatus and instruments used in laparoscopic minimally invasive surgeries and cardiac catheter-related minimally invasive surgeries. The Company distributes its products in domestic market and to overseas markets.
MEDEON BIODESIGN, INC. 
